Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
MNKD

MNKD - MannKind Corp Stock Price, Fair Value and News

5.05USD+0.32 (+6.77%)Market Closed

Market Summary

MNKD
USD5.05+0.32
Market Closed
6.77%

MNKD Alerts

  • 3 major insider sales recently.
  • Big jump in Revenue (Y/Y)
  • Big jump in Earnings (Y/Y)

MNKD Stock Price

View Fullscreen

MNKD RSI Chart

MNKD Valuation

Market Cap

1.4B

Price/Earnings (Trailing)

162.04

Price/Sales (Trailing)

6.12

EV/EBITDA

39.29

Price/Free Cashflow

443.18

MNKD Price/Sales (Trailing)

MNKD Profitability

EBT Margin

4.59%

Return on Equity

-3.69%

Return on Assets

1.76%

Free Cashflow Yield

0.23%

MNKD Fundamentals

MNKD Revenue

Revenue (TTM)

224.6M

Rev. Growth (Yr)

63.1%

Rev. Growth (Qtr)

13.32%

MNKD Earnings

Earnings (TTM)

8.5M

Earnings Growth (Yr)

208.52%

Earnings Growth (Qtr)

658.74%

Breaking Down MNKD Revenue

Last 30 days

7.3%

Last 90 days

5.1%

Trailing 12 Months

11.6%

How does MNKD drawdown profile look like?

MNKD Financial Health

Current Ratio

3.84

MNKD Investor Care

Shares Dilution (1Y)

3.03%

Diluted EPS (TTM)

0.04

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024224.6M000
2023128.4M158.1M176.5M199.0M
202270.0M65.6M76.2M99.8M
202166.3M74.5M81.4M75.4M
202061.8M61.9M62.7M65.1M
201941.8M53.0M63.1M63.0M
201812.2M13.9M16.4M27.9M
2017134.0M93.3M52.5M11.7M
201600131.1M174.8M
20120043.7M87.4M
201182.3K71.5K60.8K50.0K
201000093.0K
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of MannKind Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
May 24, 2024
blank burkhard
sold (taxes)
-77,201
4.78
-16,151
evp chief medical officer
May 21, 2024
binder steven b.
sold
-120,936
4.66
-25,952
evp special projects
May 21, 2024
thomson david
sold
-109,682
4.66
-23,537
evp genl counsel & secretary
May 18, 2024
castagna michael
sold (taxes)
-119,648
4.59
-26,067
chief executive officer
May 18, 2024
thomson david
sold (taxes)
-31,744
4.59
-6,916
evp genl counsel & secretary
May 18, 2024
tross stuart a
sold (taxes)
-28,136
4.59
-6,130
chief people & workpl officer
May 18, 2024
binder steven b.
sold (taxes)
-28,283
4.59
-6,162
evp special projects
May 17, 2024
binder steven b.
sold (taxes)
-292,475
4.59
-63,720
evp special projects
May 17, 2024
castagna michael
sold (taxes)
-1,126,580
4.59
-245,443
chief executive officer
May 17, 2024
thomson david
acquired
355,358
4.59
77,420
evp genl counsel & secretary

1–10 of 50

Which funds bought or sold MNKD recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jun 11, 2024
EverSource Wealth Advisors, LLC
new
-
411
411
-%
May 24, 2024
Cetera Investment Advisers
new
-
96,181
96,181
-%
May 23, 2024
Wellington Shields & Co., LLC
added
100
104,371
188,237
0.03%
May 21, 2024
China Universal Asset Management Co., Ltd.
added
66.6
122,320
235,320
0.03%
May 20, 2024
Virtu Financial LLC
sold off
-100
-350,000
-
-%
May 17, 2024
VIMA LLC
added
1,900
912
1,640
-%
May 16, 2024
JANE STREET GROUP, LLC
reduced
-30.22
-201,943
1,332,680
-%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-4.76
190,213
1,216,710
-%
May 15, 2024
Cipher Capital LP
new
-
60,874
60,874
0.03%
May 15, 2024
TWO SIGMA ADVISERS, LP
added
22.57
2,071,570
6,014,150
0.01%

1–10 of 39

Are Funds Buying or Selling MNKD?

Are funds buying MNKD calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own MNKD
No. of Funds

Unveiling MannKind Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
5.66%
15,248,608
SC 13G/A
Jan 25, 2024
blackrock inc.
8.3%
22,297,032
SC 13G/A
Jan 22, 2024
state street corp
4.80%
12,940,395
SC 13G/A
Feb 09, 2023
vanguard group inc
5.19%
13,664,228
SC 13G/A
Feb 08, 2023
state street corp
6.56%
17,258,797
SC 13G/A
Feb 03, 2023
blackrock inc.
8.0%
21,008,795
SC 13G/A
Feb 10, 2022
state street corp
5.19%
13,048,311
SC 13G
Feb 10, 2022
vanguard group inc
5.03%
12,645,574
SC 13G/A
Feb 01, 2022
blackrock inc.
8.4%
20,993,492
SC 13G/A
Feb 10, 2021
vanguard group inc
5.22%
12,291,714
SC 13G

Recent SEC filings of MannKind Corp

View All Filings
Date Filed Form Type Document
May 29, 2024
4
Insider Trading
May 21, 2024
144
Notice of Insider Sale Intent
May 21, 2024
144
Notice of Insider Sale Intent
May 21, 2024
4
Insider Trading
May 21, 2024
4
Insider Trading
May 21, 2024
4
Insider Trading
May 21, 2024
4
Insider Trading
May 17, 2024
4
Insider Trading
May 17, 2024
4
Insider Trading
May 17, 2024
4
Insider Trading

Peers (Alternatives to MannKind Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
55.6B
6.8B
17.55% 15.42%
-9.32
8.12
-64.45% -224.75%
22.5B
216.3K
-0.77% 465779.94%
-2.5K
104.0K
- -8.13%
20.2B
2.0B
6.10% -19.49%
-60.95
10.1
75.20% 68.82%
16.0B
2.5B
5.03% -10.77%
77.84
6.47
13.74% 186.89%
14.1B
3.8B
4.06% -3.24%
18.89
3.74
8.58% 129.81%
MID-CAP
5.4B
107.9M
0.63% 71.22%
-9.93
48.09
54.84% -28.31%
5.2B
524.1M
-1.19% -54.45%
-12.38
9.85
394.93% 39.61%
3.4B
251.0M
-5.41% -4.45%
-11.62
13.72
73.58% -86.73%
3.3B
240.7M
16.82% -26.89%
-6.96
12.77
-1.03% -213.92%
2.5B
813.8M
1.25% -38.59%
-1.5K
3.07
56.43% 98.83%
2.1B
996.6M
20.98% 97.26%
-5.3
2.12
-26.66% 65.49%
SMALL-CAP
1.8B
411.3M
-4.75% 32.39%
27.77
4.4
60.38% -34.49%
564.4M
881.7K
19.55% 492.49%
-16.72
481.06
-77.61% 33.36%
244.6M
4.2M
-16.55% 51.92%
-1.96
58.8
-66.30% 48.24%
22.1M
2.1M
40.11% 239.32%
-0.95
7.61
-13.45% 69.54%

MannKind Corp News

Latest updates
MarketBeat4 hours ago
Seeking Alpha08 May 202407:00 am

MannKind Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue13.3%66,263,00058,472,00051,253,00048,611,00040,626,00036,059,00032,825,00018,894,00011,992,00012,515,00022,211,00023,280,00017,436,00018,443,00015,352,00015,114,00016,235,00015,993,00014,595,00015,002,00017,448,000
Costs and Expenses-2.1%49,541,00050,614,00046,156,00046,890,00046,624,00048,849,00042,435,00039,348,00033,248,00036,483,00028,801,00033,553,00023,627,00042,190,00024,482,00023,029,00023,356,00027,345,00023,374,00025,954,00030,962,000
Operating Expenses-18,598,000---16,213,000----------------
  S&GA Expenses5.2%11,601,00011,024,00013,440,00014,002,00013,310,00011,616,00013,541,00015,868,00012,728,000-9,162,00017,221,00020,056,00017,413,000-7,554,00013,899,00013,670,00014,350,00015,721,00016,666,00016,609,00025,673,000
EBITDA Margin186.3%0.130.05-0.07-0.18-0.41-0.69-1.07-1.09-1.16-0.84-0.70-0.89---------
Interest Expenses-4.1%2,567,0002,677,0002,815,0006,873,0002,786,0002,997,5002,812,0006,642,0002,371,0002,769,0002,803,0003,180,0006,452,0006,259,0001,057,0001,084,0001,071,0001,021,0004,126,000564,000593,000
Income Taxes-83.1%264,0001,561,000-------------218,000------
Earnings Before Taxes267.8%10,894,0002,962,0001,721,000-5,265,000-9,795,000-17,947,000-14,432,000-29,023,000-25,998,000-28,061,000-4,426,000-35,523,000-12,916,000-26,411,000-11,473,000-10,252,000-9,322,000-14,263,000-10,370,000-12,387,000-14,883,000
EBT Margin188.0%0.05-0.05-0.18-0.30-0.55-0.88-1.28-1.33-1.34-1.07-0.97-1.16---------
Net Income658.7%10,630,0001,401,0001,721,000-5,265,000-9,795,000-17,947,000-14,432,000-29,023,000-25,998,000-28,061,000-4,426,000-35,523,000-12,916,000-26,411,000-11,255,000-10,252,000-9,322,000-14,263,000-10,370,000-12,387,000-14,883,000
Net Income Margin163.0%0.04-0.06-0.18-0.30-0.55-0.88-1.28-1.33-1.34-1.07-0.97-1.16---------
Free Cashflow-72.8%4,295,00015,804,000-2,723,000-14,273,000-7,155,000-7,472,000-28,344,000-29,148,000-23,304,000-17,537,000-19,430,000-22,501,000---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets1.2%48147532031329829529428630832123825331910996.0010380.0094.0095.0082.00101
  Current Assets2.6%38337322623022323521819318421915918028879.0066.0073.0049.0061.0062.0050.0070.00
    Cash Equivalents-19.0%19323883.0086.0086.0070.0054.0036.0067.0012452.0063.0024867.0052.0063.0039.0030.0030.008.0035.00
  Inventory-7.4%26.0029.0027.0025.0022.0022.0018.0021.008.007.007.007.005.005.005.004.003.004.004.004.004.00
  Net PPE-0.7%84.0084.0080.0070.0055.0045.0041.0038.0041.0037.0031.0028.0027.0026.0026.0026.0027.0027.0027.0027.0026.00
  Goodwill-1.6%2.002.002.002.002.002.003.003.00-------------
Liabilities-1.5%711721572574554546532533540531423436493289282282278284280278289
  Current Liabilities-4.1%10010496.0097.0082.0067.0060.0060.0053.0048.0050.0060.0073.0074.0010668.0068.0066.0064.0077.0078.00
Shareholder's Equity6.6%-229-246---255-250---------------
  Retained Earnings0.3%-3,218-3,229-3,230-3,232-3,227-3,217-3,199-3,200-3,156-3,130-3,100-3,100-3,062-3,049-3,022-3,011-3,001-2,991-2,977-2,967-2,954
  Additional Paid-In Capital0.2%2,9862,9812,9762,9692,9692,9642,9602,9372,9232,9182,9152,9122,8862,8662,8342,8292,8012,7992,7912,7692,765
Shares Outstanding0.3%271270270268264264255254252249250248---------
Float----1,084---910---1,266---358---194-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-69.1%6,70321,6788,6642,5961,156-2,376-28,073-31,982-18,248-12,347-15,184-21,447-12,731235-13,460-3,684-11,219-5,107-52,051-19,728-11,597
  Share Based Compensation1.9%3,8853,8134,6015,5803,6552,5973,6224,4222,8063,1603,1793,9261,9351,9041,2942,1851,1289441,6402,568999
Cashflow From Investing-513.5%-48,437-7,895-11,5493,66413,79215,01027,3482,022-39,506-12,5794,992-112,532-31,418-4,480-4.00-15019,850-2023,761-1,369-25,033
Cashflow From Financing-102.5%-3,474141,681-283-5,9451,1542,82519,526-1,77681397,370-590-51,490224,97718,6942,64028,1883315,04265,495-6763.00
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

MNKD Income Statement

2024-03-31
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues:  
Total revenues$ 66,263$ 40,626
Expenses:  
Cost of goods sold3,8195,530
Research and development10,0135,605
Selling11,60113,310
General and administrative10,72810,542
(Gain) loss on foreign currency transaction(1,399)954
Total expenses49,54146,624
Income (loss) from operations16,722(5,998)
Other income (expense):  
Interest income, net3,4341,302
Interest expense on financing liability(2,447)(2,424)
Interest expense(2,567)(2,786)
Interest expense on liability for sale of future royalties(4,248) 
Other income 111
Total other expense(5,828)(3,797)
Income (loss) before income tax expense10,894(9,795)
Income tax expense264 
Net income (loss)$ 10,630$ (9,795)
Net income (loss) per share - basic$ 0.04$ (0.04)
Weighted average shares used to compute net income (loss) per share - basic270,356263,969
Net income (loss) per share - diluted$ 0.04$ (0.04)
Weighted average shares used to compute net income (loss) per share - diluted324,733263,969
Commercial product sales  
Revenues:  
Total revenues$ 18,764$ 17,562
Collaborations and services  
Revenues:  
Total revenues24,84811,386
Expenses:  
Cost of revenue14,77910,683
Royalties  
Revenues:  
Total revenues$ 22,651$ 11,678

MNKD Balance Sheet

2024-03-31
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents$ 193,272$ 238,480  
Short-term investments107,45756,619  
Accounts receivable, net19,91214,901  
Inventory26,44228,545  
Prepaid expenses and other current assets36,01934,848  
Total current assets383,102373,393  
Property and equipment, net83,62084,220  
Goodwill1,9311,931  
Other intangible asset1,0531,073  
Long-term investments3,7267,155  
Other assets7,4477,426  
Total assets480,879475,198  
Current liabilities:    
Accounts payable7,1499,580  
Accrued expenses and other current liabilities42,29142,036  
Financing liability — current9,8729,809  
Midcap credit facility - current20,00020,000  
Liability for sale of future royalties - current10,5379,756  
Deferred revenue — current7,6019,085  
Recognized loss on purchase commitments — current2,4463,859  
Total current liabilities99,896104,125  
Mann Group convertible note8,8298,829  
Accrued interest - Mann Group convertible note5556  
Financing liability — long term94,20794,319  
Midcap credit facility - long term8,10513,019  
Senior convertible notes227,214226,851  
Liability for sale of future royalties - long term137,418136,054  
Recognized loss on purchase commitments — long term60,28760,942  
Operating lease liability3,6453,925  
Deferred revenue — long term67,74169,794  
Milestone liabilities3,4523,452  
Total liabilities710,849721,366  
Commitments and contingencies (Note 14)  
Stockholders' deficit:    
Undesignated preferred stock, $0.01 par value - 10,000,000 shares authorized; no shares issued or outstanding as of March 31, 2024 or December 31, 2023  
Common stock, $0.01 par value - 800,000,000 shares authorized; 270,801,781 and 270,034,495 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively2,7032,700  
Additional paid-in capital2,986,1042,980,539  
Accumulated deficit(3,218,777)(3,229,407)  
Total stockholders' deficit(229,970)(246,168)$ (255,396)$ (250,538)
Total liabilities and stockholders' deficit$ 480,879$ 475,198  
MNKD
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes, and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults. The company's product pipeline also includes Tyvaso DP Treprostinil, an inhalation powder for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; MNKD-101, a nebulized formulation of clofazimine, for the treatment of severe chronic and recurrent pulmonary infections, including nontuberculous mycobacterial lung disease, and idiopathic pulmonary and cystic fibrosis. In addition, it has collaboration and license agreement with United Therapeutics Corporation for development, regulatory, and commercial activities of Tyvaso DPI; co-promotion agreement with Vertice Pharma to promote Thyquidity; and collaboration agreement with Thirona to evaluate the therapeutic for the treatment of pulmonary fibrosis. Further, the company has supply and distribution agreement with Biomm S.A. for the commercialization of Afrezza in Brazil; and license and distribution agreement with Cipla Ltd. for the marketing and distribution of Afrezza in India. MannKind Corporation was incorporated in 1991 and is headquartered in Danbury, Connecticut.
 CEO
 WEBSITEmannkindcorp.com
 INDUSTRYBiotechnology
 EMPLOYEES391

MannKind Corp Frequently Asked Questions


What is the ticker symbol for MannKind Corp? What does MNKD stand for in stocks?

MNKD is the stock ticker symbol of MannKind Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of MannKind Corp (MNKD)?

As of Wed Jun 12 2024, market cap of MannKind Corp is 1.29 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MNKD stock?

You can check MNKD's fair value in chart for subscribers.

What is the fair value of MNKD stock?

You can check MNKD's fair value in chart for subscribers. The fair value of MannKind Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of MannKind Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for MNKD so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is MannKind Corp a good stock to buy?

The fair value guage provides a quick view whether MNKD is over valued or under valued. Whether MannKind Corp is cheap or expensive depends on the assumptions which impact MannKind Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MNKD.

What is MannKind Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Jun 12 2024, MNKD's PE ratio (Price to Earnings) is 151.77 and Price to Sales (PS) ratio is 5.73. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MNKD PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on MannKind Corp's stock?

In the past 10 years, MannKind Corp has provided -0.214 (multiply by 100 for percentage) rate of return.